However, concerns over its impact on LDL and HDL (as well as anemia, neutrophil suppression, and liver enzymes elevations) lingered and questions regarding whether these laboratory measures would translate into clinical events were raised.

FORBES: Pfizer's Key Drug Walks A Tightrope